Abstract
Liver transplantation has been increasingly offered as a curative treatment option to a highly selected group of patients with unresectable perihilar cholangiocarcinoma.1 Patients who meet the transplant criteria at our institution undergo a protocolized therapy with neoadjuvant chemoradiation and brachytherapy followed by liver transplantation, with a 5-year disease-free survival rate of 55% to 65%.2
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have